Status:
COMPLETED
First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro
Lead Sponsor:
Contipro Pharma a.s.
Conditions:
Alveolar Osteitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Alveolar Osteitis (AO) is a complication following extraction of a tooth. AO manifests by localized pain in and around the extraction site where the postoperative blood clot has been disintegrated. Th...
Detailed Description
Alveolar Osteitis (AO) is a complication following extraction of a tooth. AO manifests by localized pain in and around the extraction site where the postoperative blood clot has been disintegrated. Th...
Eligibility Criteria
Inclusion
- Patient with diagnosed alveolar osteitis
- Minimal age limit 18 years
- Patient capable to fully understand and comply with the requirements of the study
Exclusion
- Patient younger than 18 years
- Pregnant or lactant woman
- Patient diagnosed with cancer
- Patient with a history of radiotherapy in the head and neck area
- Patient undergone bisphosphonate treatment within the last two years
- Patient who had been given antibiotics less than two weeks prior the AO onset
- Patient with hypersensitivity or allergy to any substances contained in the tested drug
- Patient who smokes more than 10 cigarettes per day
Key Trial Info
Start Date :
September 11 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2016
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04091399
Start Date
September 11 2015
End Date
February 12 2016
Last Update
September 16 2019
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
IchtysDent s.r.o
Brno, Czechia, 60200
2
University Hospital Brno, Clinic of Oral, Maxillary and Facial Surgery
Brno, Czechia, 62500
3
Prouzovi s.r.o.
Dvůr Králové nad Labem, Czechia, 54401
4
University Hospital Hradec Králové, Department of Dentistry
Hradec Králové, Czechia, 50005